Al-Dury S, Wahlström A, Wahlin S, et al. Pilot Study with IBAT Inhibitor A4250 for the Treatment of Cholestatic Pruritus in Primary Biliary Cholangitis. AASLD 2017, abstract 69.
Adjuvant sorafenib na RFA verbetert prognose van HCC-patiënten
aug 2022 | Maag-darm-leveroncologie